Neurologists’ Group Warns Families of Limits of Controversial Alzheimer’s Drug

Published on November 18, 2021

Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines.”Aducanumab is not…

Read Full Article (External Site)